Webb Michael J. 4
4 · NxStage Medical, Inc. · Filed Dec 2, 2011
Insider Transaction Report
Form 4
Webb Michael J.
SVP, Quality & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2011-12-01$4.54/sh+10,000$45,400→ 27,390 total - Exercise/Conversion
Stock Option (Right to Buy)
2011-12-01−10,000→ 32,000 totalExercise: $4.54From: 2008-04-27Exp: 2015-03-26→ Common Stock (10,000 underlying) - Sale
Common Stock
2011-12-01$19.71/sh−10,000$197,136→ 17,390 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 19, 2011.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.54 to $19.82. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- [F3]This option was granted on March 27, 2008 and vests over four years in equal monthly installments.